Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose

BACKGROUND: Topical high-precision piezo-print delivery of microdoses of latanoprost achieved significant IOP reduction consistent with the eyedropper effect but with a 75% reduced exposure to drugs and preservatives. Prostaglandin analogs are a mainstay glaucoma therapy. However, conventional eyedr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquale, Louis R, Lin, Shan, Weinreb, Robert N, Tsai, James C, Kramm, Robert L, Ianchulev, Tsontcho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276603/
https://www.ncbi.nlm.nih.gov/pubmed/30568423
http://dx.doi.org/10.2147/OPTH.S185027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276603/
https://www.ncbi.nlm.nih.gov/pubmed/30568423
http://dx.doi.org/10.2147/OPTH.S185027

Ejemplares similares